LE-AON

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameLE-AON
Drug Alias NameLiposomal encapsulated antisense oligonucleotide c-raf-1LEraf-AON-ETULE-AON c-rafLE-rafAONLE-AON
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionC-Raf kinase inhibitorsRNA inhibitors
TargetsRibonucleic AcidC-Raf kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGeorgetown University (The)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInsys Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A